Brought to you by
SERAM 2014 / S-1196
Cum Laude
Papel del modelo bicompartimental del movimiento incoherente intravóxel (IVIM) en la caracterización de lesiones torácicas
Congress: SERAM 2014
Poster No.: S-1196
Type: Presentación Electrónica Educativa
Keywords: Mediastino, Pulmón, Tórax, RM-Difusión/Perfusión, RM-Imagen Funcional, Aplicaciones informáticas-Detección, diagnóstico, Inflamación, Metástasis, Neoplasia
Authors: J. Broncano1, T. Martín Noguerol2, L. Alcalá Mata2, J. Sánchez González3, A. Luna Alcalá2; 1Córdoba/ES, 2Jaén/ES, 3Madrid/ES
DOI:10.1594/seram2014/S-1196

Bibliografía

 

1.            Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497-505. Epub 1988/08/01.

2.            Bisdas S. Are we ready to image the incoherent molecular motion in our minds? Neuroradiology. 2013;55(5):537-40. Epub 2013/04/23.

3.            Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246(3):697-722. Epub 2008/01/16.

4.            Bernardin L, Douglas NH, Collins DJ, Giles SL, O'Flynn EA, Orton M, et al. Diffusion-weighted magnetic resonance imaging for assessment of lung lesions: repeatability of the apparent diffusion coefficient measurement. European radiology. 2014;24(2):502-11. Epub 2013/11/28.

5.            Regier M, Schwarz D, Henes FO, Groth M, Kooijman H, Begemann PG, et al. Diffusion-weighted MR-imaging for the detection of pulmonary nodules at 1.5 Tesla: intraindividual comparison with multidetector computed tomography. Journal of medical imaging and radiation oncology. 2011;55(3):266-74. Epub 2011/06/24.

6.            Luna A, Sanchez-Gonzalez J, Caro P. Diffusion-weighted imaging of the chest. Magnetic resonance imaging clinics of North America. 2011;19(1):69-94. Epub 2010/12/07.

7.            Liu H, Liu Y, Yu T, Ye N. Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions. European radiology. 2010;20(4):807-15. Epub 2009/10/29.

8.            Abdel Razek AA, Elkammary S, Elmorsy AS, Elshafey M, Elhadedy T. Characterization of mediastinal lymphadenopathy with diffusion-weighted imaging. Magnetic resonance imaging. 2011;29(2):167-72. Epub 2010/10/19.

9.            Koyama H, Ohno Y, Aoyama N, Onishi Y, Matsumoto K, Nogami M, et al. Comparison of STIR turbo SE imaging and diffusion-weighted imaging of the lung: capability for detection and subtype classification of pulmonary adenocarcinomas. European radiology. 2010;20(4):790-800. Epub 2009/09/19.

10.          Bains LJ, Zweifel M, Thoeny HC. Therapy response with diffusion MRI: an update. Cancer imaging : the official publication of the International Cancer Imaging Society. 2012;12:395-402. Epub 2012/10/02.

11.          Ohno Y, Koyama H, Yoshikawa T, Matsumoto K, Aoyama N, Onishi Y, et al. Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy. AJR American journal of roentgenology. 2012;198(1):75-82. Epub 2011/12/24.

12.          Nomori H, Mori T, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. The Journal of thoracic and cardiovascular surgery. 2008;135(4):816-22. Epub 2008/04/01.

13.          Wu LM, Xu JR, Gu HY, Hua J, Chen J, Zhang W, et al. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better? The Journal of surgical research. 2012;178(1):304-14. Epub 2012/05/01.

14.          Kim YN, Yi CA, Lee KS, Kwon OJ, Lee HY, Kim BT, et al. A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer. European radiology. 2012;22(7):1537-46. Epub 2012/03/01.

15.          Razek AA, Elmorsy A, Elshafey M, Elhadedy T, Hamza O. Assessment of mediastinal tumors with diffusion-weighted single-shot echo-planar MRI. Journal of magnetic resonance imaging : JMRI. 2009;30(3):535-40. Epub 2009/07/25.

16.          Shin KE, Yi CA, Kim TS, Lee HY, Choi YS, Kim HK, et al. Diffusion-weighted MRI for distinguishing non-neoplastic cysts from solid masses in the mediastinum: problem-solving in mediastinal masses of indeterminate internal characteristics on CT. European radiology. 2014;24(3):677-84. Epub 2013/11/02.

17.          Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Seminars in oncology. 2002;29(1):2-17. Epub 2002/02/12.

18.          Lanphear BP, Buncher CR. Latent period for malignant mesothelioma of occupational origin. Journal of occupational medicine : official publication of the Industrial Medical Association. 1992;34(7):718-21. Epub 1992/07/01.

19.          Robinson BW, Lake RA. Advances in malignant mesothelioma. The New England journal of medicine. 2005;353(15):1591-603. Epub 2005/10/14.

20.          Wang ZJ, Reddy GP, Gotway MB, Higgins CB, Jablons DM, Ramaswamy M, et al. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics : a review publication of the Radiological Society of North America, Inc. 2004;24(1):105-19. Epub 2004/01/20.

21.          Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. The Journal of thoracic and cardiovascular surgery. 1999;117(1):54-63; discussion -5. Epub 1998/12/31.

22.          Tsao AS, Wistuba I, Roth JA, Kindler HL. Malignant pleural mesothelioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(12):2081-90. Epub 2009/03/04.

23.          Edwards JG, Cox G, Andi A, Jones JL, Walker RA, Waller DA, et al. Angiogenesis is an independent prognostic factor in malignant mesothelioma. British journal of cancer. 2001;85(6):863-8. Epub 2001/09/15.

24.          Strizzi L, Catalano A, Vianale G, Orecchia S, Casalini A, Tassi G, et al. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. The Journal of pathology. 2001;193(4):468-75. Epub 2001/03/29.

25.          Yamamuro M, Gerbaudo VH, Gill RR, Jacobson FL, Sugarbaker DJ, Hatabu H. Morphologic and functional imaging of malignant pleural mesothelioma. European journal of radiology. 2007;64(3):356-66. Epub 2007/10/24.

26.          Zucali PA, Giaccone G. Biology and management of malignant pleural mesothelioma. Eur J Cancer. 2006;42(16):2706-14. Epub 2006/09/23.

27.          Basu S, Saboury B, Torigian DA, Alavi A. Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging. 2011;13(5):801-11. Epub 2010/12/08.

28.          O'Brien ME, Watkins D, Ryan C, Priest K, Corbishley C, Norton A, et al. A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2006;17(2):270-5. Epub 2005/12/01.

29.          Vogelzang NJ. Standard therapy for the treatment of malignant pleural mesothelioma. Lung Cancer. 2005;50 Suppl 1:S23-4. Epub 2005/11/18.

30.          Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003;21(14):2636-44. Epub 2003/07/16.

31.          Bonomo L, Feragalli B, Sacco R, Merlino B, Storto ML. Malignant pleural disease. European journal of radiology. 2000;34(2):98-118. Epub 2000/06/30.

32.          Sager S, Ergul N, Ciftci H, Cermik TF. False positive (18)F-FDG-PET/CT findings in a patient with talc pleurodesis. Hellenic journal of nuclear medicine. 2010;13(2):179-80. Epub 2010/09/03.

33.          Coolen J, De Keyzer F, Nafteux P, De Wever W, Dooms C, Vansteenkiste J, et al. Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experience. Radiology. 2012;263(3):884-92. Epub 2012/04/27.

34.          Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest. 1995;108(4):1122-8. Epub 1995/10/01.

35.          Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR American journal of roentgenology. 1999;172(4):1039-47. Epub 1999/12/10.

36.          Marom EM, Erasmus JJ, Pass HI, Patz EF, Jr. The role of imaging in malignant pleural mesothelioma. Seminars in oncology. 2002;29(1):26-35. Epub 2002/02/12.

37.          Gill RR, Umeoka S, Mamata H, Tilleman TR, Stanwell P, Woodhams R, et al. Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. AJR American journal of roentgenology. 2010;195(2):W125-30. Epub 2010/07/24.

38.          Kawashima A, Libshitz HI. Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR American journal of roentgenology. 1990;155(5):965-9. Epub 1990/11/01.

39.          Sahin AA, Coplu L, Selcuk ZT, Eryilmaz M, Emri S, Akhan O, et al. Malignant pleural mesothelioma caused by environmental exposure to asbestos or erionite in rural Turkey: CT findings in 84 patients. AJR American journal of roentgenology. 1993;161(3):533-7. Epub 1993/09/01.

40.          Benard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest. 1998;114(3):713-22. Epub 1998/09/22.

41.          Bury T, Paulus P, Dowlati A, Corhay JL, Rigo P, Radermecker MF. Evaluation of pleural diseases with FDG-PET imaging: preliminary report. Thorax. 1997;52(2):187-9. Epub 1997/02/01.

42.          Schneider DB, Clary-Macy C, Challa S, Sasse KC, Merrick SH, Hawkins R, et al. Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma. The Journal of thoracic and cardiovascular surgery. 2000;120(1):128-33. Epub 2000/07/08.

43.          Maskell NA, Butland RJ. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax. 2003;58 Suppl 2:ii8-17. Epub 2003/05/03.

44.          Baysal T, Bulut T, Gokirmak M, Kalkan S, Dusak A, Dogan M. Diffusion-weighted MR imaging of pleural fluid: differentiation of transudative vs exudative pleural effusions. European radiology. 2004;14(5):890-6. Epub 2003/08/09.

45.          Inan N, Arslan A, Akansel G, Arslan Z, Elemen L, Demirci A. Diffusion-weighted MRI in the characterization of pleural effusions. Diagn Interv Radiol. 2009;15(1):13-8. Epub 2009/03/06.

46.          Gill RR, Gerbaudo VH, Jacobson FL, Trotman-Dickenson B, Matsuoka S, Hunsaker A, et al. MR imaging of benign and malignant pleural disease. Magnetic resonance imaging clinics of North America. 2008;16(2):319-39, x. Epub 2008/05/14.

47.          Weber MA, Bock M, Plathow C, Wasser K, Fink C, Zuna I, et al. Asbestos-related pleural disease: value of dedicated magnetic resonance imaging techniques. Investigative radiology. 2004;39(9):554-64. Epub 2004/08/17.

48.          Theros EG, Feigin DS. Pleural tumors and pulmonary tumors: differential diagnosis. Seminars in roentgenology. 1977;12(3):239-47. Epub 1977/07/01.

49.          Rosado-de-Christenson ML, Abbott GF, McAdams HP, Franks TJ, Galvin JR. From the archives of the AFIP: Localized fibrous tumor of the pleura. Radiographics : a review publication of the Radiological Society of North America, Inc. 2003;23(3):759-83. Epub 2003/05/13.

50.          Tateishi U, Nishihara H, Morikawa T, Miyasaka K. Solitary fibrous tumor of the pleura: MR appearance and enhancement pattern. Journal of computer assisted tomography. 2002;26(2):174-9. Epub 2002/03/09.

51.          Inaoka T, Takahashi K, Miyokawa N, Ohsaki Y, Aburano T. Solitary fibrous tumor of the pleura: apparent diffusion coefficient (ADC) value and ADC map to predict malignant transformation. Journal of magnetic resonance imaging : JMRI. 2007;26(1):155-8. Epub 2007/07/31.

52.          Henschke CI, Yankelevitz DF, Davis SD. Pleural diseases: multimodality imaging and clinical management. Current problems in diagnostic radiology. 1991;20(5):155-81. Epub 1991/09/01.

53.          Sahn SA. Malignancy metastatic to the pleura. Clinics in chest medicine. 1998;19(2):351-61. Epub 1998/07/01.

54.          Shuman LS, Libshitz HI. Solid pleural manifestations of lymphoma. AJR American journal of roentgenology. 1984;142(2):269-73. Epub 1984/02/01.

55.          Hierholzer J, Luo L, Bittner RC, Stroszczynski C, Schroder RJ, Schoenfeld N, et al. MRI and CT in the differential diagnosis of pleural disease. Chest. 2000;118(3):604-9. Epub 2000/09/16.

56.          Falaschi F, Battolla L, Zampa V, Cioni R, Cambi L, Antonelli A, et al. [Comparison of computerized tomography and magnetic resonance in the assessment of benign and malignant pleural diseases]. La Radiologia medica. 1996;92(6):713-8. Epub 1996/12/01. Confronto fra Tomografia Computerizzata e Risonanza Magnetica nella valutazione delle malattie pleuriche benigne e maligne.

 

POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
SHARE THIS POSTER
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more